The study will test and compare the efficacy of a single essential amino acid valine with a combination of essential amino acids (EAA) supplement on fatigue, frailty, and cognitive function in end-stage kidney disease (ESKD) patients undergoing hemodialysis (HD) treatment.
Male or Female
Age 18-64 years
Receiving 3 x weekly in clinic hemodialysis for at least 6 months
Hypersensitivity to amino acid(s) and/or any excipient
Clinical documentation of COVID-19
Concomitant intake of amino acids supplements
Current use or abuse of alcohol, marijuana, narcotic, or other substances
The University of Texas Health Science Center at San Antonio
Lead sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator
IIMS-UT Health San Antonio
Collaborator